Jun 27 |
Vertex (VRTX) Rises 16.5% YTD: Time to Bet On the Stock?
|
Jun 27 |
Is CRISPR Therapeutics Stock a Buy? One Analyst Thinks the Biotech Is "Very Undervalued."
|
Jun 27 |
3 Biotech Stocks That Could Make Your Grandchildren Rich
|
Jun 25 |
Everyone's Talking About Vertex Pharmaceuticals. Is It Time to Buy?
|
Jun 24 |
Vertex Pharmaceutical Incorporated. (VRTX): Analysts are Bullish on this Healthcare Stock’s Strong Financial Performance in Q1
|
Jun 24 |
Vertex’s VX-880 shows promise in Phase I/II type 1 diabetes trial
|
Jun 21 |
Vertex releases positive phase 1/2 results on VX-880 for type 1 diabetes
|
Jun 21 |
Vertex Announces Positive Results From Ongoing Phase 1/2 Study of VX-880 for the Treatment of Type 1 Diabetes Presented at the American Diabetes Association 84th Scientific Sessions
|
Jun 21 |
Reshma Kewalramani Is Guiding Vertex Pharmaceuticals to Its Next Big Thing
|
Jun 21 |
Forget Eli Lilly, Buy This Magnificent Biotech Stock Instead
|